Cleveland Biolabs (CBLI) Shares Rally as Efficacy Study for CBLB502 Showed Strong Survival Results
Go back to Cleveland Biolabs (CBLI) Shares Rally as Efficacy Study for CBLB502 Showed Strong Survival Results| Cleveland Biolabs, Inc. (NASDAQ: CBLI) | Delayed: 3.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.17 | 52 Week High | $4.58 | |||
| Open | $156.00 | 52 Week Low | $1.45 | |||
| Day High | $3.17 | P/E | N/A | |||
| Day Low | $3.17 | EPS | $-0.49 | |||
| Volume | 30 | |||||
